Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid A phosphate groups are essential anionic components of the lipopolysaccharide (LPS) molecule found in the outer membrane of Gram-negative bacteria (Raetz et al., 2007, PubMed: 17589885). These phosphate groups, typically located at the 1 and 4' positions of the glucosamine backbone, provide a negative charge that is crucial for stabilizing the outer membrane through the bridging of divalent cations like calcium and magnesium (Nikaido, 2003, PubMed: 12730534). Biologically, they are recognized by the TLR4/MD-2 receptor complex in humans, triggering a potent inflammatory response that can lead to sepsis and septic shock (Park et al., 2009, PubMed: 19915566). From a therapeutic perspective, these phosphate groups serve as the primary binding site for cationic antimicrobial peptides and polymyxin antibiotics, such as colistin and polymyxin B (Velkov et al., 2013, PubMed: 24122106). Drugs target these groups via electrostatic interactions, which displaces stabilizing cations and leads to membrane disruption and bacterial cell death (Trimble et al., 2016, PubMed: 27530111). However, bacteria can develop resistance by modifying these phosphate groups with moieties like phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, reducing the overall negative charge and drug affinity (Liu et al., 2016, PubMed: 26603172). This target is also a focus for the development of endotoxin-neutralizing agents designed to treat sepsis by preventing LPS from binding to host receptors (Matsuura, 2013, PubMed: 23435152).
Electrostatic binding to negatively charged phosphate groups, displacing divalent cations and disrupting the bacterial outer membrane.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide lipid A phosphate groups.